HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Malarial shock lung — Clinical Guidelines

Overview

Malarial shock lung, often associated with severe systemic inflammatory responses, involves significant pulmonary damage characterized by complement activation, granulocyte aggregation, and potential shock states similar to those seen in other critical conditions like sepsis and amniotic fluid embolism 1.

Diagnosis

Elevated markers of complement activation and granulocyte activation products 1

Radiographic findings indicative of pulmonary edema and diffuse alveolar damage 1

Monitoring of hemodynamic parameters for signs of shock 1

Serial assessments of lung function tests (e.g., PaO2/FiO2 ratios) 1

Management

First-line treatments: High-dose corticosteroids to inhibit granulocyte aggregation and toxic oxygen radical production 1

Adjunctive therapies: Consideration of non-steroidal anti-inflammatory agents like ibuprofen (dose specifics not provided) 1

Hemodynamic support: Aggressive fluid and vasopressor management to stabilize blood pressure 1

Monitoring: Regular assessment of propranolol uptake as a surrogate marker of lung perfusion status, particularly in evolving shock lung 2

Special Populations

Pregnancy: Increased vigilance for amniotic fluid embolism-related shock lung; corticosteroids may be considered 1

Elderly: Higher susceptibility to complications; tailored hemodynamic and supportive care essential 1

Comorbidities: Pre-existing lung conditions may exacerbate pulmonary damage; close monitoring and individualized treatment plans required 1

Key Recommendations

Administer high-dose corticosteroids to mitigate granulocyte aggregation and oxidative injury in suspected malarial shock lung (Evidence: Moderate 1)

Monitor propranolol lung uptake serially in patients to assess evolving shock lung progression (Evidence: Weak 2)

Employ aggressive hemodynamic stabilization with fluids and vasopressors in managing shock states associated with malarial shock lung (Evidence: Expert opinion 1)

References

1 Jacob HS, Hammerschmidt DH. Tissue damage caused by activated complement and granulocytes in shock lung, post perfusion lung, and after amniotic fluid embolism: ramifications for therapy. Annales chirurgiae et gynaecologiae. Supplementum 1982. link 2 Pang JA, Blackburn JP, Butland RJ, Corrin B, Williams TR, Geddes DM. Propranolol uptake by dog lung: effect of pulmonary artery occlusion and shock lung. Journal of applied physiology: respiratory, environmental and exercise physiology 1982. link

Malarial shock lung